The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global contract research organization (CRO) services market is expected to exhibit a CAGR of 7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Contract research organizations (CROs) provide research-based services on a contract to government organizations in the pharmaceutical, biotechnology and related sectors. They can be either large, international full-sized organizations or small, niche specialty groups that offer drug and device research and development (R&D) services, including drug discovery, preclinical research, clinical research, etc. These services are time and cost-efficient and assist in accessing intricate knowledge of regulatory requirements and audits.
Rapid technological advancements and increasing globalization are leading various biotech and pharmaceutical companies to outsource their research and development (R&D) activities to CROs. This represents one of the key factors impelling the growth of the market. Moreover, the key players are investing significantly in clinical and non-clinical research activities outsourced to CROs. They are also engaged in merger and acquisition (M&A) activities to expand their overall reach. For instance, Covance Drug Development, a segment of Laboratory Corporation of America Holdings, purchased Envigo RMS, LLC, a key provider of research models and services to enhance the global research capabilities of Covance’s non-clinical drug development business. Furthermore, CROs are gaining prominence across the healthcare sector for research, medications, and drug delivery services. Therefore, the escalating demand for these services from healthcare providers is creating a favorable outlook for the market growth. Other factors, including the growing demand for effective drugs and healthcare devices, along with the high cost of product development and rising patient population, are projected to strengthen the market in the upcoming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global contract research organization (CRO) services market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, therapeutic area and end user.
Breakup by Type:
Breakup by Therapeutic Area:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International Inc., Covance Inc. (Laboratory Corporation of America Holdings), ICON Clinical Research Limited, IQVIA Inc., Medpace Inc., Parexel International Corporation, PPD Inc., PRA Health Sciences Inc., SGS SA, Syneos Health Inc., and WuXi AppTec Co. Limited.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Therapeutic Area, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Charles River Laboratories International Inc., Covance Inc. (Laboratory Corporation of America Holdings), ICON Clinical Research Limited, IQVIA Inc., Medpace Inc., Parexel International Corporation, PPD Inc., PRA Health Sciences Inc., SGS SA, Syneos Health Inc., and WuXi AppTec Co. Limited|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at